Novavax
NVAX
82 hedge funds and large institutions have $35.7M invested in Novavax in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 11 closing their positions.
210% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 10
166% more call options, than puts
Call options by funds: $13.6M | Put options by funds: $5.12M
1% more funds holding
Funds holding: 81 → 82 (+1)
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
0.89% more ownership
Funds ownership: 28.74% → 29.62% (+0.89%)
10% less capital invested
Capital invested by funds: $39.7M → $35.7M (-$3.95M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.51M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$800K |
| 3 |
BlackRock
New York
|
+$479K |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$418K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$271K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$877K |
| 2 |
Two Sigma Advisers
New York
|
-$590K |
| 3 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
-$510K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$435K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$409K |
NVAX Hedge Fund Activity: Q3 2019 in Review
82 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2019, worth a combined $35.7M — down 10% from $39.7M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NVAX positions and 11 closed out — a net gain of 1 holder — while 31 added to existing stakes and 10 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $1.51M. The largest seller was Morgan Stanley, cutting an estimated $877K.
- 82 institutional investors held Novavax (NVAX) as of Q3 2019, up from 81 in Q2 2019.
- Funds reported $35.7M of Novavax stock for Q3 2019, down 10% quarter-over-quarter.
- 12 funds opened new Novavax positions in Q3 2019 and 11 closed out, a net change of +1 holder.
- The largest Novavax buyer in Q3 2019 was JP Morgan Chase, an estimated $1.51M added.
- The largest Novavax seller in Q3 2019 was Morgan Stanley, an estimated $877K sold.
Based on aggregated 13F filings for Q3 2019.